HIV/AIDS News and Research

RSS
Weekly cycles of once-daily anti-HIV drugs could reduce cost of HIV treatment

Weekly cycles of once-daily anti-HIV drugs could reduce cost of HIV treatment

Cystic Fibrosis Foundation Therapeutics awards $21 million to Vertex

Cystic Fibrosis Foundation Therapeutics awards $21 million to Vertex

WHO to tackle heart disease, diabetes, cancers, road safety as well as diseases

WHO to tackle heart disease, diabetes, cancers, road safety as well as diseases

Positive Chinese results for HIV test kit

Positive Chinese results for HIV test kit

Weekly cycles of once-daily anti-drugs could reduce cost of HIV treatment

Weekly cycles of once-daily anti-drugs could reduce cost of HIV treatment

Diabetes drug improves metabolic changes associated with HIV combination therapy

Diabetes drug improves metabolic changes associated with HIV combination therapy

FDA finalizes new rule on donor eligibility for human tissues and cells

FDA finalizes new rule on donor eligibility for human tissues and cells

Causes of hepatitis and potential therapies that may improve care presented in study

Causes of hepatitis and potential therapies that may improve care presented in study

Britain's youth complacent about HIV/AIDS

Britain's youth complacent about HIV/AIDS

Canadian Statement to the World Health Assembly focuses on AIDS

Canadian Statement to the World Health Assembly focuses on AIDS

New book highlights pros and cons of medical use of cannabis

New book highlights pros and cons of medical use of cannabis

Benitec acquires Avocel to focus on rapid development of hepatitis C therapeutics

Benitec acquires Avocel to focus on rapid development of hepatitis C therapeutics

Manipulation of the body’s own natural killer cells to destroy cells containing the HIV virus

Manipulation of the body’s own natural killer cells to destroy cells containing the HIV virus

UN round table looks at rapid spread of HIV/AIDS in prisons

UN round table looks at rapid spread of HIV/AIDS in prisons

GlaxoSmithKline and Boehringer Ingelheim agree to assess the development of important HIV medicines for the developing world

GlaxoSmithKline and Boehringer Ingelheim agree to assess the development of important HIV medicines for the developing world

Guidelines for FUZEON (enfuvirtide) are published today in AIDS

Guidelines for FUZEON (enfuvirtide) are published today in AIDS

HHS to ensure safe, effective drugs delivered to developing countries under the President's $15 billion plan for AIDS relief

HHS to ensure safe, effective drugs delivered to developing countries under the President's $15 billion plan for AIDS relief

The federal government should expand its role in the financing of HIV/AIDS treatment for low-income Americans

The federal government should expand its role in the financing of HIV/AIDS treatment for low-income Americans

Plans for once-daily, fixed-dose combination of three anti-HIV drugs

Plans for once-daily, fixed-dose combination of three anti-HIV drugs

CDC announces new goals and organizational structure

CDC announces new goals and organizational structure

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.